Hyloris On Track To Meet 2024 Target During Half-Year Update

Company Aims To Expand Its Portfolio To 30 Products By 2024

 
• By Chloe Kent

Hyloris CEO Stijn Van Rompay said the firm is on track to meet its target of 30 portfolio products by 2024, delivering a confident Q2 half-year update despite some pushback from the US Food and Drug Administration on its Maxigesic IV compound.

Train approaching train station on top of Mount Rigi in canton of Schwyz, Switzerland
Hyloris remains on track to meet its 2024 ambitions, according to the company's CEO • Source: Shutterstock

More from Earnings

More from Business